APA

Takano K., Matsumura K., Watanabe Y., Yamada T., Kubo H., Naitou Y., Narita Y., Kuzuhara S. & Takeda K. (20000605). [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain]. : Kaku igaku. The Japanese journal of nuclear medicine.

Chicago

Takano K, Matsumura K, Watanabe Y, Yamada T, Kubo H, Naitou Y, Narita Y, Kuzuhara S and Takeda K. 20000605. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain]. : Kaku igaku. The Japanese journal of nuclear medicine.

Harvard

Takano K., Matsumura K., Watanabe Y., Yamada T., Kubo H., Naitou Y., Narita Y., Kuzuhara S. and Takeda K. (20000605). [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain]. : Kaku igaku. The Japanese journal of nuclear medicine.

MLA

Takano K, Matsumura K, Watanabe Y, Yamada T, Kubo H, Naitou Y, Narita Y, Kuzuhara S and Takeda K. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain]. : Kaku igaku. The Japanese journal of nuclear medicine. 20000605.